JobCubby JobCubby
Sign up
Artiva Biotherapeutics

Artiva Biotherapeutics

We are dedicated to making safe and effective cell therapies accessible to any cancer patient who may benefit.

LinkedIn
Location
—
Roles tracked
0
In pipeline
0
Tracking since
—

At a glance

You're tracking 0 roles at Artiva Biotherapeutics. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
113 people
Headquarters
San Diego, California
Founded
2019
Type
Privately Held
Total funding
$498.0M

Artiva Biotherapeutics is an immunotherapy company with the ability to produce off-the-shelf, allogeneic NK cell therapies at a massive scale. Our mission is to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers. Our lead program, AlloNK®, is an allogeneic, non-genetically modified NK cell therapy candidate designed to enhance the activity of monoclonal antibodies or NK cell engagers. AlloNK is currently in clinical trials in combination with rituximab for treatment of systemic lupus erythematosus (SLE) in patients with active lupus nephritis and for treatment of Non-Hodgkin Lymphoma, as well as in combination with Affimed’s innate cell engager AFM13 for the treatment of patients with relapsed/refractory CD30-positive lymphomas.

cell therapy cancer nk cells nk cell therapy and car-nk
1 open role at Artiva Biotherapeutics on the job board

Open roles at Artiva Biotherapeutics